Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Pari V. Pandharipande

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-2855-9119; OpenAlex author ID A5003218663; NIH RePORTER profile ID 8696620. Sources: OpenAlex.

Their work

Papers
13 (first author 0, last author 4)
Trials
0
Grants
1
Labs led
2
Collaborators
40
Papers, trials and grants by year

2015: 2 papers · 2016: 1 paper · 2017: none · 2018: 3 papers · 2019: 2 papers · 2020: 3 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper, 1 grant

Papers 13

  1. Cost-Effectiveness Analysis of Screening for Pancreatic Cancer Among High-Risk Populations. Last author DOI 10.1200/op.23.00495↗
  2. Genetic testing to guide screening for pancreatic ductal adenocarcinoma: Results of a microsimulation model. Last author DOI 10.1016/j.pan.2022.05.003↗
  3. Diabetes, Weight Change, and Pancreatic Cancer Risk. Co-author DOI 10.1001/jamaoncol.2020.2948↗
  4. Imaging-based Risk Scores for Treatment Selection in Early Pancreatic Cancer: A Step Forward for Tailored Treatment. Co-author DOI 10.1148/radiol.2020202567↗
  5. Genetic and Circulating Biomarker Data Improve Risk Prediction for Pancreatic Cancer in the General Population. Co-author DOI 10.1158/1055-9965.epi-19-1389↗
  6. Pancreatic cancer treatment costs, including patient liability, by phase of care and treatment modality, 2000-2013. Co-author DOI 10.1097/md.0000000000018082↗
  7. Neoadjuvant FOLFIRINOX for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis. Co-author DOI 10.1634/theoncologist.2018-0114↗
  8. Disparities in cancer outcomes across age, sex, and race/ethnicity among patients with pancreatic cancer. Co-author DOI 10.1002/cam4.1277↗
  9. Progression to pancreatic ductal adenocarcinoma from pancreatic intraepithelial neoplasia: Results of a simulation model. Last author DOI 10.1016/j.pan.2018.07.009↗
  10. Are Staging Computed Tomography (CT) Scans of the Chest Necessary in Pancreatic Adenocarcinoma? Co-author DOI 10.1245/s10434-018-6764-3↗
  11. Early Pancreatic Ductal Adenocarcinoma Survival Is Dependent on Size: Positive Implications for Future Targeted Screening. Last author DOI 10.1097/mpa.0000000000000587↗
  12. Screening for Pancreatic Adenocarcinoma in BRCA2 Mutation Carriers: Results of a Disease Simulation Model. Co-author DOI 10.1016/j.ebiom.2015.11.005↗
  13. Targeted screening of individuals at high risk for pancreatic cancer: results of a simulation model. Co-author DOI 10.1148/radiol.14141282↗

Grants 1

  1. Precision Management of Cystic Precursors to Pancreatic Cancer R01CA237133↗

Closest collaborators

The 25 strongest of 40 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chin Hur · 8 shared papers, 2015–2022 · strength 0.69
  2. Mary Linton B. Peters · 4 shared papers, 2018–2024 · strength 0.59
  3. Chung Yin Kong · 7 shared papers, 2015–2019 · strength 0.52
  4. Angela C. Tramontano · 6 shared papers, 2015–2019 · strength 0.46
  5. Mark Anderson · 1 shared paper, 2020 · strength 0.24
  6. Ana Babić · 2 shared papers, 2020 · strength 0.18
  7. Chen Yuan · 2 shared papers, 2020 · strength 0.18
  8. Edward L. Giovannucci · 2 shared papers, 2020 · strength 0.18
  9. Kimmie Ng · 2 shared papers, 2020 · strength 0.18
  10. Peter Kraft · 2 shared papers, 2020 · strength 0.18
  11. Brian Matthew Wolpin · 2 shared papers, 2020 · strength 0.18
  12. Charles S. Fuchs · 2 shared papers, 2020 · strength 0.18
  13. Deborah Schrag · 2 shared papers, 2018–2019 · strength 0.17
  14. Ryan David Nipp · 2 shared papers, 2018–2019 · strength 0.17
  15. William Robert Brugge · 3 shared papers, 2015–2016 · strength 0.16
  16. Theodore Sunki Hong · 2 shared papers, 2018–2019 · strength 0.15
  17. Carlos F. Fernandez-del Castillo · 2 shared papers, 2018–2019 · strength 0.15
  18. Cristina Rosa Ferrone · 2 shared papers, 2018–2019 · strength 0.15
  19. Michael Hayden Rosenthal · 1 shared paper, 2020 · strength 0.09
  20. Douglas Adam Rubinson · 1 shared paper, 2020 · strength 0.09
  21. Andrew J. Aguirre · 1 shared paper, 2020 · strength 0.09
  22. Jonathan Andrew Nowak · 1 shared paper, 2020 · strength 0.09
  23. Chris Sander · 1 shared paper, 2020 · strength 0.09
  24. Natalia I. Khalaf · 1 shared paper, 2020 · strength 0.09
  25. Jihye Kim · 1 shared paper, 2020 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.